Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Silver Prices Hit Record High Above ₹1.95 Lakh/kg as Gold Jumps: What’s Driving the Bullion Rally on 11 December 2025?

Silver Prices Hit Record High Above ₹1.95 Lakh/kg as Gold Jumps: What’s Driving the Bullion Rally on 11 December 2025?

India’s bullion markets turned white-hot on Thursday, 11 December 2025, as silver prices smashed fresh lifetime highs and gold extended its rally, powered by a global wave of optimism after the US Federal Reserve delivered yet another interest rate cut. From Multi Commodity Exchange (MCX) futures to physical markets tracked by the India Bullion and Jewellers Association (IBJA), silver prices logged sharp, broad-based gains in just 48 hours, while gold quietly moved higher alongside. Jagran+2livehindustan.com+2 Silver Hits New Lifetime High on MCX On MCX, silver futures exploded to an unprecedented level during trade on 11 December: Earlier in the day,
11 December 2025
·
The Trade Desk (TTD) Stock on December 11, 2025: New 52‑Week Lows, Bullish Forecasts and a High‑Stakes 2026 Rebound Bet

The Trade Desk (TTD) Stock on December 11, 2025: New 52‑Week Lows, Bullish Forecasts and a High‑Stakes 2026 Rebound Bet

Updated December 11, 2025 The Trade Desk, Inc. (NASDAQ: TTD) is having one of those “gravity hurts” years on the stock market. As of this afternoon, the ad‑tech leader’s shares trade around $37, down roughly two‑thirds in 2025, even though revenue and profits are still growing at a double‑digit pace. TipRanks At the same time, Wall Street analysts keep slapping “Buy” ratings and price targets that imply the stock could double or more from here. Options traders, meanwhile, are leaning bearish. And high‑profile investor Cathie Wood is quietly hoovering up shares. Here’s a detailed rundown of today’s news, forecasts and
11 December 2025
··
Centessa Pharmaceuticals (CNTA) Stock on December 11, 2025: CEO Shake‑Up, Analyst Upgrades and 2026 Orexin Catalysts

Centessa Pharmaceuticals (CNTA) Stock on December 11, 2025: CEO Shake‑Up, Analyst Upgrades and 2026 Orexin Catalysts

Date: December 11, 2025 Centessa Pharmaceuticals plc (NASDAQ: CNTA) is back in the spotlight after a major leadership announcement and a sharp intraday pullback in its share price. On December 11, 2025, the company unveiled a CEO transition that will take effect at the start of 2026, just as its orexin program heads toward pivotal studies.GlobeNewswire+1 Shares of Centessa traded around the high‑$20s on Thursday afternoon, down meaningfully on the day following the news. Earlier in the session, financial data service GuruFocus flagged an 8.4% drop to roughly $27 per share, underscoring how sensitive the stock remains to shifts in
11 December 2025
··
Marvell Technology (MRVL) Stock Falls as Amazon Trainium Drama Collides With Record AI Data Center Growth

Marvell Technology (MRVL) Stock Falls as Amazon Trainium Drama Collides With Record AI Data Center Growth

December 11, 2025 Marvell Technology, Inc. (NASDAQ: MRVL) is having one of those “only-in-AI-2015” weeks: the company just posted record data‑center revenue, announced a multibillion‑dollar optical‑interconnect acquisition, and rolled out new connectivity products for hyperscale AI clusters — yet the stock is sliding as investors argue over whether Marvell has lost a critical Amazon AI chip deal. As of early afternoon on December 11, Marvell shares were trading around $88, down roughly 4–5% on the day and about 31% below their 52‑week high near $127. MarketBeat+1 Behind that red number is a tug‑of‑war between very strong fundamentals and noisy —
11 December 2025
···
eToro Group Ltd. (ETOR) Stock on December 11, 2025: Latest News, Forecasts, and Analysis

eToro Group Ltd. (ETOR) Stock on December 11, 2025: Latest News, Forecasts, and Analysis

eToro Group Ltd. (NASDAQ: ETOR) is having one of those “everything at once” moments: strong Q3 numbers, fresh November business metrics, new products, institutional money flowing in, and yet a share price still well below its IPO highs. That combination is exactly why ETOR is showing up so often on stock screens, watchlists, and trading chats right now. Wikipedia+2StockAnalysis+2 Below is a structured look at where eToro’s stock stands as of December 11, 2025, and what the latest news and forecasts are actually saying. 1. ETOR stock today: price, performance, and range At around midday on December 11, 2025, eToro
11 December 2025
·
Extreme Networks (EXTR) Stock Forecast: Analyst Targets, 2026 Guidance and Institutional Flows as of December 11, 2025

Extreme Networks (EXTR) Stock Forecast: Analyst Targets, 2026 Guidance and Institutional Flows as of December 11, 2025

Extreme Networks, Inc. (NASDAQ: EXTR), the cloud‑driven networking vendor behind the ExtremeCloud IQ and Platform ONE portfolio, is back in the spotlight as investors digest fresh guidance, bullish analyst calls and a new wave of institutional activity.Wikipedia+1 As of December 11, 2025, EXTR is trading around $17.3–$17.4 per share, down roughly 4–5% on the day, with a 52‑week range of $10.10 to $22.89 and a market capitalization of about $2.3 billion.StockAnalysis That leaves the stock more than 70% above its 52‑week low, but still about 24% below its high, a classic “mid‑range” setup where the narrative matters as much as
11 December 2025
Arm Holdings (ARM) Stock on December 11, 2025: Oracle Shock, 200‑Day Breakdown and the AI Growth Story

Arm Holdings (ARM) Stock on December 11, 2025: Oracle Shock, 200‑Day Breakdown and the AI Growth Story

Arm Holdings plc (NASDAQ: ARM) is back in the spotlight today as its share price slides alongside other AI‑linked names, even while Wall Street’s growth forecasts and AI narratives stay aggressively bullish. On December 11, 2025, Arm stock is trading around $135, down roughly 5% on the day, after briefly falling below $134 and under its 200‑day moving average near $138.Nasdaq+1 The move comes as disappointing Oracle earnings trigger a sharp pullback in AI‑related stocks and reignite “AI bubble” worries across global markets.The Guardian+1 Key Takeaways for Arm Stock Today 1. How Arm Holdings Stock Is Trading on 11 December
11 December 2025
···
Onto Innovation (ONTO) Stock on December 11, 2025: Latest Price, Q3 Earnings, Semilab Deal and 2026 Forecasts

Onto Innovation (ONTO) Stock on December 11, 2025: Latest Price, Q3 Earnings, Semilab Deal and 2026 Forecasts

December 11, 2025 – Markets / Semiconductors / Stock Analysis Onto Innovation Inc. (NYSE: ONTO), a mid‑cap supplier of semiconductor process control and inspection tools, is back in focus after a sharp intraday pullback, fresh short‑interest data and the recent closing of a $495 million acquisition that reshapes its growth outlook for 2026. Onto Innovation+1 Below is a detailed look at today’s trading, the latest fundamentals, new strategic moves and what Wall Street expects from ONTO stock over the next 12 months. Onto Innovation stock price today Around early afternoon U.S. trading on Thursday, December 11, 2025, Onto Innovation shares
11 December 2025
····
Super Micro Computer (SMCI) Stock Today: AI Server Leader Faces Margin Squeeze — Latest News, Forecasts and Analysis

Super Micro Computer (SMCI) Stock Today: AI Server Leader Faces Margin Squeeze — Latest News, Forecasts and Analysis

Super Micro Computer, Inc. (“Supermicro”, Nasdaq: SMCI) remains one of the purest public plays on AI data‑center hardware, but as of December 11, 2025, its stock is trading under sustained pressure. Shares are hovering in the low‑$33 range, down about 5–6% intraday and locked in a prolonged correction from 2025 highs above $60. The stock has fallen roughly 9% over the past year, badly trailing a computer‑hardware peer group that’s surged more than 50% in the same period. Finviz Investors are wrestling with a sharp margin and cash‑flow squeeze, ongoing regulatory overhang from earlier accounting probes, and questions about whether
11 December 2025
···
Hut 8 Corp (HUT) Stock on December 11, 2025: Price, News, Analyst Ratings and 2026 Forecast

Hut 8 Corp (HUT) Stock on December 11, 2025: Price, News, Analyst Ratings and 2026 Forecast

Updated December 11, 2025 Hut 8 stock today: volatile trading near the top of its 52‑week range Hut 8 Corp (Nasdaq, TSX: HUT) – the energy‑infrastructure and Bitcoin mining company – is trading around the mid‑$40s on December 11, 2025. Real‑time data shows the shares near $45.30, with an intraday range between $42.84 and $45.30, down about 1.6% on the day in U.S. trading. Over the last twelve months, Hut 8 has swung between roughly $10.04 at the low and $57.29 at the high, giving it a market capitalization of about $4.85 billion. The stock currently carries a negative price‑to‑earnings
11 December 2025
··
SharpLink Gaming (SBET) Stock in December 2025: Ethereum Treasury Giant at a Discount After 2,600% Spike and 86% Crash

SharpLink Gaming (SBET) Stock in December 2025: Ethereum Treasury Giant at a Discount After 2,600% Spike and 86% Crash

SharpLink Gaming, Inc. (NASDAQ: SBET) has become one of the wildest stories on the public markets in 2025: a former sports-betting tech company that turned itself into an Ethereum treasury vehicle, rocketed more than 2,600%… and then gave back roughly 86% from its peak as the “crypto treasury” boom deflated. Los Angeles Times As of midday on December 11, 2025, SBET trades around $11.36 per share, with a 52‑week range of $2.26 to $124.12, a market cap of about $2.23 billion, and a beta near 12, putting it firmly in the “strap-in-and-hold-on” category of volatility. StockAnalysis Below is a deep
11 December 2025
·
10x Genomics (TXG) Stock: Citi Downgrade, AI Partnerships and 2026 Forecast After December 11 Sell-Off

10x Genomics (TXG) Stock: Citi Downgrade, AI Partnerships and 2026 Forecast After December 11 Sell-Off

10x Genomics, Inc. (NASDAQ: TXG) — a leading player in single-cell and spatial biology — is back in the spotlight after a sharp share-price drop on 11 December 2025. A high-profile analyst downgrade from Citigroup hit the stock the same morning, even as the company pushes forward with ambitious AI collaborations and cancer atlas projects that could shape its long-term growth story. MarketScreener+2StockStory+2 Below is a detailed look at what moved TXG today, how Wall Street views the stock heading into 2026, and what recent partnerships and earnings say about its future. Key Takeaways 10x Genomics Stock Today: December 11,
11 December 2025
···
Vertiv (VRT) Stock Pulls Back After Wolfe Downgrade – Can the AI Data Center Winner Keep Climbing in 2026?

Vertiv (VRT) Stock Pulls Back After Wolfe Downgrade – Can the AI Data Center Winner Keep Climbing in 2026?

Vertiv Holdings Co (NYSE: VRT), one of Wall Street’s favorite “picks-and-shovels” plays on artificial intelligence and data centers, is taking a breather after a huge multi‑year run. As of midday trading on December 11, 2025, Vertiv shares were changing hands around $169–170, down roughly 7% on the day and well below last month’s record near $199.StockAnalysis+1 The pullback follows a high‑profile downgrade from Wolfe Research and disappointment over the stock’s latest miss for S&P 500 index inclusion, even as fundamentals and most analyst forecasts remain strongly positive. 1. What just happened to Vertiv stock? Vertiv’s recent slide was triggered on
11 December 2025
··
Telix Pharmaceuticals (TLX) Stock: Varian Deal, ProstACT Milestone and Class Actions Redraw the 2025 Outlook

Telix Pharmaceuticals (TLX) Stock: Varian Deal, ProstACT Milestone and Class Actions Redraw the 2025 Outlook

December 11, 2025 Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) is ending 2025 in a paradoxical position: commercially successful, rich in late‑stage oncology assets, but trading near its 12‑month lows amid SEC scrutiny, an FDA setback and a growing stack of class‑action lawsuits. At the same time, new clinical milestones and a fresh collaboration with Varian are reinforcing the long‑term radiopharmaceutical growth story. This overview pulls together today’s news, the latest clinical and legal developments, and current analyst forecasts as of 11 December 2025. Telix share price today: depressed after a volatile year By midday in New York on 11
11 December 2025
···
Affirm Holdings (AFRM) Stock on December 11, 2025: Shopify Expansion, Institutional Buying and Lofty Price Targets Put BNPL Leader Back in Focus

Affirm Holdings (AFRM) Stock on December 11, 2025: Shopify Expansion, Institutional Buying and Lofty Price Targets Put BNPL Leader Back in Focus

As of December 11, 2025, Affirm Holdings, Inc. (NASDAQ: AFRM) is once again one of the most closely watched names in fintech. The buy now, pay later (BNPL) pioneer has turned the corner into profitability, deepened its global partnership with Shopify, attracted fresh institutional money—and still trades at one of the richest valuations in the sector. With shares recently changing hands in the high‑$60s to low‑$70s after closing at $70.86 on December 10, Affirm sits well above its 52‑week low of around $30.90 but below its late‑August peak near $100.Nasdaq+1 Investors now face a classic growth‑stock question: is the rally
11 December 2025
··
Comstock Resources (CRK) Stock: December 11, 2025 News, Price Drop, Forecasts and AI-Powered Gas Demand Outlook

Comstock Resources (CRK) Stock: December 11, 2025 News, Price Drop, Forecasts and AI-Powered Gas Demand Outlook

As of the afternoon of December 11, 2025, Comstock Resources, Inc. (NYSE: CRK) is trading around $21.6 per share, down roughly 6% on the day and about 9.8% over the past week, though the stock remains just over 40% higher than it was a year ago.TradingView+1 Within its 52‑week range of roughly $14.65 to $31.17, CRK now sits about 30% below its high but nearly 48% above its low, underlining how sharp this week’s reversal has been.Investing.com The pullback comes even as fresh research from Zacks highlights Comstock as one of three natural‑gas stocks poised to benefit from a forecast
11 December 2025
··
New Gold Inc (NGD) Stock: 201% Rally, $7 Billion Coeur Mining Buyout and December 2025 Analyst Outlook

New Gold Inc (NGD) Stock: 201% Rally, $7 Billion Coeur Mining Buyout and December 2025 Analyst Outlook

As of December 11, 2025, New Gold Inc (NYSE American: NGD, TSX: NGD) has turned into one of the most closely watched gold miners on the market. The Canadian producer has enjoyed a 201% share‑price surge over the past year, posted record free cash flow, agreed to a $7 billion all‑stock acquisition by Coeur Mining, and now sits under an unusually bullish wall of analyst “Buy” ratings. Finimize+2Q4 CDN+2 Where New Gold stock stands today On the Toronto Stock Exchange, New Gold shares recently traded around C$11.37 intraday on December 11, 2025, up more than 5% on the day and
11 December 2025
·····
Hecla Mining (HL) Stock Hits 52‑Week High as Silver Soars: December 2025 Outlook, Forecasts and Risks

Hecla Mining (HL) Stock Hits 52‑Week High as Silver Soars: December 2025 Outlook, Forecasts and Risks

Hecla Mining Company (NYSE: HL) has turned into one of 2025’s surprise market darlings. On 11 December 2025, the stock pushed to a new 52‑week high of $18.13, capping a year in which it has surged more than 200%, far outpacing both silver prices and the broader equity market.Investing.com+2Simply Wall St+2 At around $17–18 per share and a market capitalization of roughly $12 billion, Hecla has graduated from niche silver producer to mainstream mid‑cap momentum name.Investing.com+1 Yet Wall Street’s Hecla Mining stock forecasts still sit notably below the current price, and analysts are split on whether HL is a sustainable
11 December 2025
··
Polestar Automotive (PSNY) Stock Plunges After Reverse Split – Latest News, Analyst Forecasts and 2025–2026 Outlook

Polestar Automotive (PSNY) Stock Plunges After Reverse Split – Latest News, Analyst Forecasts and 2025–2026 Outlook

December 11, 2025 Polestar Automotive Holding UK PLC (NASDAQ: PSNY), the Swedish premium electric-vehicle maker backed by China’s Geely, is having one of its most volatile weeks since listing. After a 1‑for‑30 reverse stock split and a fresh Nasdaq warning, the newly consolidated Polestar stock has swung wildly, crashing to fresh 52‑week lows even as the company reports almost 50% revenue growth for 2025 so far. Ad-Hoc News+1 As of late trading on December 11, PSNY is changing hands around $12–13 per share (about $12.45 last trade), following a two‑day rout that included a more than 20% plunge on Wednesday
11 December 2025
·
Wave Life Sciences (WVE) Stock on December 11, 2025: Obesity Breakthrough, 180% Rally, $350M Offering and Fresh Analyst Targets

Wave Life Sciences (WVE) Stock on December 11, 2025: Obesity Breakthrough, 180% Rally, $350M Offering and Fresh Analyst Targets

Updated: December 11, 2025 – all figures and ratings as of publication; this article is for information only and is not investment advice. Key takeaways WVE stock today: from under‑the‑radar biotech to market spotlight Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical‑stage biotechnology company focused on RNA‑based medicines, has gone from relative obscurity to market headline in a matter of days. As of late trading on December 11, 2025, WVE shares change hands around $17.06, with an intraday high of $20.19 and low of $16.75 on heavy volume. That pullback comes after a spectacular multi‑session surge: In parallel, an insider
11 December 2025
···
1 … 429 430 431 432 433 … 535

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop